ATAC - Pharmacokinetics (PK) Sub-Protocol
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Anastrozole|DRUG: Tamoxifen
Sponsor: AstraZeneca